Global Speakers


Andrew Saunders

Board Director & Chair of Community Advisory Committee

Eastern Health

Forum Chairperson


Panel: Who Is Responsible For AI Misdiagnosis? Regulatory Perspectives On AI

Eastern Health logo


Mark Middleton


Icon Group


Use Of AI To Personalize Cancer Care At Icon Group

Icon Group logo

A radiation therapist with extensive management experience, Mark brings essential clinical expertise and astute strategic vision to his role as CEO of Icon Group. His leadership style is simple; he is committed to nurturing the capabilities of his team while challenging them to deliver exceptional cancer care – and growing the business to ensure that care is available to as many people as possible.

From the Group’s earliest days, Mark advocated for providing services not just in metropolitan centres but also in outer-metro and regional communities throughout Australia. Under his leadership, Icon has grown from 12 to 30 cancer centres through a combination of strategic acquisitions and new builds. Over 50% of this network services outer-metro and regional areas. Further centres have also been announced in Victoria and regional New South Wales, with all expected to open in the medium term.

He has also overseen robust international expansion into New Zealand, Singapore, the wider South East Asian region and Hong Kong. Significantly, under Mark’s leadership Icon Group became the first Australian healthcare company to enter the Chinese market. These achievements are a reflection of Mark’s clear vision for Icon Group and his capacity to forge strong and productive partnerships with local and international healthcare providers.

Prior to his current role, Mark worked in cancer care in North America and Europe before founding Radiation Oncology Queensland (ROQ) – now part of Icon Group. He has published 25 peer reviewed scientific papers and is a frequently invited keynote speaker both nationally and internationally. In 2018, he was announced as a Director on the inaugural City Cancer Challenge Board.

Mark was a State Finalist for the Australian Institute of Management (AIM) Queensland Manager of the Year in 2014, regional winner of the AIM Excellence Award 2015 and finalist in CEO Magazine’s 2016 and 2019 Executive of the Year Awards. He has a Master of Business Administration from Deakin University and is a Fellow of both the AIM and the Australian Institute of Radiography.


Dr. Amith Shetty

Clinical Director, Patient Experience and System Performance Support

NSW Ministry of Health


Identifying Patients At Risk Of Sepsis For Early Intervention With Predictive Algorithm And AI Profiling

NSW Ministry of Health logo


Dr. Sonu Bhaskar

Founding Director

NSW Brain Clot Bank


  • Panel: Who Is Responsible For AI Misdiagnosis? Regulatory Perspectives On AI
  • Designing Futuristic Telemedicine Using Artificial Intelligence And Robotics In The COVID-19 Era



Prof. Antonio Di Ieva

Consultant Neurosurgeon

Macquarie Neurosurgery


AI In Computational Neurosurgery And Clinical Neurosciences

Macquarie Neurosurgery logo

Professor Antonio Di Ieva is a full-time academic neurosurgeon at the Macquarie University Hospital, Sydney, and consultant at Macquarie Neurosurgery. He is Professor at Macquarie University, professor of neurosurgery in Italy, and Associate Professor of Neuroanatomy at the Medical University of Vienna, Austria. His clinical specialities include neuro-oncology, pituitary and skull base surgery, spine and peripheral nerve surgery and pain treatment as well.

Professor Di Ieva is also a clinical and computational neuroscientist. His primary research interests are in neuroanatomy, neuroimaging and computational neurosciences, focused on the application of advanced computer-based analyses in the field of the clinical neurosciences. He has published more than 130 peer-reviewed articles, 3 books, including the only textbook on the application of computational fractal-based analysis to the brain science, and many book chapters. Moreover, he has won 7 international awards in Neurosurgery and Neurosciences, including the John Mitchell Crouch Fellowship 2019, the most prestigious research award of the Royal Australasian College of Surgeons (RACS). He is founded by the NHMRC and in 2019 he was awarded a prestigious Australian Research Council (ARC) Future Fellowship with a research project in machine vision.

At Macquarie University, he has founded and leads the Computational NeuroSurgery (CNS) Lab, aimed to the application of advanced computational modelling (e.g., fractal-based analysis, Artificial Intelligence, radiomics and advanced image analysis) to the study of brain diseases of neurosurgical interest, namely brain tumours and cerebrovascular diseases, amongst others.


Dr. Sandeep Reddy

Associate Professor

Deakin University


  • Using AI In Medical Diagnostics
  • Panel: Who Is Responsible For AI Misdiagnosis? Regulatory Perspectives On AI

Deakin University logo

Sandeep is an Artificial Intelligence (AI) in Healthcare researcher based at the Deakin School of Medicine besides functions as a certified health informatician and a World Health Organization recognized digital health expert. He has a medical and healthcare management background and has completed machine learning/ health informatics training from various sources. He is currently engaged in research about the safety, quality and explainability of the application of AI in healthcare delivery in addition to developing AI models to treat and manage chronic diseases. Also, he has authored several articles and books about the use of AI in Medicine. Further, he has set up local and international forums to promote the use of AI in Healthcare in addition to sitting on various international committees focusing on AI in Healthcare.


Prof. Geoff Webb

Research Director, Monash Data Futures Institute

Monash University


Monash University And Alfred Hospital’s AI Superbug System: Supporting Super Bug Diagnosis, Treatment And Prevention

Monash University logo


Rabia Khan

Head, Commissioned Research & Engagement

The George Institute for Global Health


Roundtable Discussion: The Hippocratic Oath Meets AI: Ethics And Fraud

The George Institute for Global Health logo


Rita Matulionyte

Senior Lecturer in Law

Macquarie University


Panel: Who Is Responsible For AI Misdiagnosis? Regulatory Perspectives On AI

Macquarie University logo

Dr Rita Matulionyte is a senior lecturer and researcher in law at Macquarie Law School, Macquarie University. She is an expert in intellectual property and technology law, with her most recent research focusing on legal and regulatory issues surrounding Artificial Intelligence. Rita has over 40 research papers published by leading international publishers and was invited to present her research in conferences in Europe, US, Japan, Hong Kong and Australia. She has prepared expert reports for the European Commission, the European Patent Office, and for the governments of South Korea and Lithuania. She is a member of the management committee of the Australian Society for Computers and Law (AUSCL) and is an active member of Intellectual Property Society for Australia and New Zealand (IPSANZ).


Alison Choy Flannigan


Hall & Wilcox


Panel: Who Is Responsible For AI Misdiagnosis? Regulatory Perspectives On AI

Hall & Wilcox logo

Alison Choy Flannigan, Partner, leads the Health & Community team at National law firm, Hall & Wilcox. Alison is also company secretary of the National Foundation for Medical Research and Innovation and the Publications Officer of the Healthcare and Life Sciences Law Committee of the International Bar Association.

With over 20 years of corporate, commercial and regulatory experience, Alison has specialized in advising clients in the health, aged care, disability, life sciences and community sectors. She is previously general counsel of Ramsay Health Care Limited, Australia’s largest private hospital operator, company secretary of Research Australia and the preferred legal adviser for many years for NSW Health on clinical trial agreements and research governance

Alison has advised Australian companies and multinational pharmaceutical and medical device and health care companies establish business in Australia. She advises on issues such as intellectual property, regulatory (including TGA), corporate and commercial advice, mergers & acquisitions, capital raisings and therapeutic goods product recalls.

Alison is a market leader, having been listed in Best Lawyers for each and every year since 2008 for health & aged care, retirement living and biotechnology in Australia, Doyles Guide as a Preeminent Leading Health and Aged Care Lawyer in each and every year since 2017, as well as being a finalist for Lawyers Weekly Partner of the Year, Health, in each and every year since 2016 and winning this prestigious award in 2019 and 2020.


Dr. Steven Weidong Su, PhD

Associate Professor, School of Biomedical Engineering, Faculty of Engineering and IT

University of Technology Sydney


Transforming Patient Rehab Through Robot-Assisted AI-Exoskeleton

University of Technology Sydney logo

Steven Su, PhD is Associate Professor at UTS and a core member of its Centre for Health Technologies (CHT) and Global Big Data Technologies Centre (GBDTC). He has over 20 years of experience in system control and optimisation, biomedical system modelling and parameter estimation, and rehabilitation engineering, having published 1 book and over 270 refereed research papers in these areas. He is a senior member of IEEE and a member of AusBiotech. He holds editorial positions for renowned journals in his field, including current Editor for International Journal of Circuit Theory and Applications, Associate Editor for International Journal of Advanced Robotic Systems, and editorial member for Applied Soft Computing.

Steven Su has led several major research projects at UTS CHT and GBDTC. He developed a research team for robot rehabilitation. In the last five years, this research team has received both external and internal research funding for stroke diagnosis and rehabilitation (e.g., the ‘Lam Yuen Trust and Australia China Economics Trade & Culture Association Scholarship for Medical Research’ and ‘FEIT/UTS Blue Sky Research Scheme’ funding). Based on this support, the two remote controllable rehabilitation robots: the AI Exoskeleton (funded by Techcelerator and winner of the Most Innovative Prototype Award 2020) and the ankle rehabilitation robot, have been developed for rehabilitation. He also developed an electronic nose (NOS.E) gas sensing system, which received significant industry funding (including CRC-P) and was recognised by the NSW State iAwards 2020 for Business and Industry Solution.

 Steven Su received his B.E.(Hon) and M.E. degrees from Harbin Institute of Technology, China, and his Ph.D. degree from the Australian National University (ANU), Australia.


Dr. Jeremy Hudson

Clinical Director

North Queensland Skin Centre


The Future Of Skin Cancer Detection Could Be Artificial Intelligence

NQSC logo

Dr Hudson is the lead Australian researcher for Fotofinder ATBM’s International Trial for Artificial Intelligence imaging, and is involved in the development of novel technologies for early skin cancer detection, such as the use of Super High Magnification Imaging (Confoscopy).

Dr Hudson works full time in Skin Cancer Medicine and Surgery and has extensive qualifications in the field, performing regular skin checks and a wide range of treatments including non-surgical therapies, basic excisions and complex flap and graft surgery.

Jeremy strongly believes that since Australia has one of the highest rates of skin cancer in the world, our patients deserve access to the best and latest advancements in skin cancer medicine.

Dr Hudson also holds the position of Senior Lecturer at James Cook University, where he writes and teaches courses in skin cancer medicine, dermoscopy, and advanced graft and flap surgery. He is currently developing a series of online written and video resources for skin cancer surgical training.

Dr Hudson is an active member of several other research and training organizations including the Dermatology Special Interests Group (RACGP), the Skin Cancer College of Australasia, and has assisted in research projects on surgical outcomes, histological sampling and tissue samples for cell line studies.

Jeremy is a strong advocate of education for both patients and doctors, and has worked extensively in both paid and volunteer positions to deliver high quality care and raise local training standards.


Teena Pisarev

Managing Director NSW/ACT & Singapore

Virtus Health


Virtus Health Case Study: Leveraging AI Technology To Help On Increasing Success Rates In IVF Pregnancies

Virtus Health logo


Dr. Tanya Petrovich

Business Innovation Manager

Dementia Australia


Dementia Australia Case Study: World-First AI Avatar To Improve Dementia Care

Dementia Australia logo

Dr Tanya Petrovich is Business Innovation Manager, Centre for Dementia Learning, Dementia Australia.

Tanya leads the team in applying innovations in technology throughout dementia care education. This includes the Virtual Dementia Experience, an immersive sensory environment at the Perc Walkley Dementia Learning Centre which won the 2014 Victorian iAward, National iAward for Education and APICTA award for E-learning, 2015 Victorian Public Health Award-Gold Winner. The Virtual Dementia Experience gives participants an understanding of what it might be like to have dementia and also how the built environment impacts on the person living with dementia.

More recently in 2016 EDIE- Educational Dementia Immersive Experience was released for use on the Samsung – Oculus Gear VR. This mobile technology has opened the opportunity to have these virtual experiences available to people not only in Australia but worldwide. The EDIE project was awarded the project Innovation Award for projects less than$2.5Mil from the Simulation Australasia Innovation Awards 2017 and also the Best Aged Care Software Development and Deployment Award at the Information Technology in Aged Care awards (ITAC) 2017.

Her team is currently working on a project to create an artificially intelligent Avatar living with dementia.


Professor Paul Kennedy

Director, Biomedical Data Science Laboratory, Head of Discipline (Data Analytics/Artificial Intelligence)

University of Technology Sydney

University of Technology Sydney logo


Jo Hunter

Co-Director of lab MoTILa

Monash University

Monash University logo


Dr. Christopher Bain

Professor of Digital Health

Monash University

Monash University logo


Vicky Stavroulakis




Roundtable Discussion: Challenges In AI Adoption And Scaling

PintarHealthConnect logo


A/Prof Joseph Mathew

Deputy Director of Alfred Health Trauma Services

The Alfred Hospital


Helping COVID-19 Patients To Stay Safe with AI Backed Pandemic Intervention And Monitoring System

Alfred Hospital logo


David Bunker

Executive Director (CEO)

Brisbane Diamantina Health Partners (Confirming)


Precision Medicine With AI: Combining AI Technologies With Genomic Data To Predict Patient Response To Cancer Treatment

Brisbane Diamantina Health Partners logo


Mark Nevin


Mark has held several executive positions in international peak membership bodies overseeing policy, strategy, regulation and government affairs. He has wide ranging experience of governance, policy development and the implementation of strategy. His qualifications include a BSc Economics, MSc in European Politics and Governance, certificates in leadership and the AICD company director’s course. He also became a Fellow of the Australasian Institute of Digital Health in 2020 in recognition of his work on telehealth and artificial intelligence.

Mark is interim CEO of the Royal Australian and New Zealand College of Radiologists until October 2021. Before that, he oversaw the Faculties of Clinical Radiology and Radiation Oncology and led RANZCR’s policy and advocacy work for six years. Prior to coming to Australia, Mark headed up policy and strategy for the optometry sector in the UK, Republic of Ireland and the European Union. Mark’s interest and expertise in health stems from 10 years delivering front line care as an optometrist in the UK.

Moreover, he has extensive governance experience, serving on numerous national and international committees, including four years as a board member of the European Council of Optometry and Optics.